Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing
详细信息 查看全文
- 作者：Bryan S. Reatini ; Elliot Ensink ; Brian Liau ; Jessica Y. Sinha ; Thomas W. Powers ; Katie Partyka ; Marshall Bern ; Randall E. Brand ; Pauline M. Rudd ; Doron Kletter ; Richard Drake ; Brian B. Haab
- 刊名：Analytical Chemistry
- 出版年：2016
- 出版时间：December 6, 2016
- 年：2016
- 卷：88
- 期：23
- 页码：11584-11592
- 全文大小：674K
- ISSN：1520-6882
文摘
Glycans are critical to protein biology and are useful as disease biomarkers. Many studies of glycans rely on clinical specimens, but the low amount of sample available for some specimens limits the experimental options. Here we present a method to obtain information about protein glycosylation using a minimal amount of protein. We treat proteins that were captured or directly spotted in small microarrays (2.2 mm × 2.2 mm) with exoglycosidases to successively expose underlying features, and then we probe the native or exposed features using a panel of lectins or glycan-binding reagents. We developed an algorithm to interpret the data and provide predictions about the glycan motifs that are present in the sample. We demonstrated the efficacy of the method to characterize differences between glycoproteins in their sialic acid linkages and N-linked glycan branching, and we validated the assignments by comparing results from mass spectrometry and chromatography. The amount of protein used on-chip was about 11 ng. The method also proved effective for analyzing the glycosylation of a cancer biomarker in human plasma, MUC5AC, using only 20 μL of the plasma. A glycan on MUC5AC that is associated with cancer had mostly 2,3-linked sialic acid, whereas other glycans on MUC5AC had a 2,6 linkage of sialic acid. The on-chip glycan modification and probing (on-chip GMAP) method provides a platform for analyzing protein glycosylation in clinical specimens and could complement the existing toolkit for studying glycosylation in disease.